Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018

4 Section 2 amended (Interpretation)


In section 2(1), insert in their appropriate alphabetical order:

CBD product has the meaning given in section 2A

non-psychoactive THC analogue means a substance that—


occurs naturally in cannabis; and


is not capable of inducing more than a minor psychoactive effect, by any means, in a person; and


has a structure substantially similar to that of—


a tetrahydrocannabinol; or


an isomer, ester, or ether of a tetrahydrocannabinol; or


an ester or ether of an isomer of a tetrahydrocannabinol; or


a salt of any substance described in subparagraphs (i) to (iii)


In section 2(1), definition of controlled drug analogue, after paragraph (c), insert:


a non-psychoactive THC analogue


After section 2(1A), insert:


In this Act, a person requires palliation if, in the opinion of a medical practitioner or nurse practitioner, the person has an advanced progressive life-limiting condition and is nearing the end of their life.